Hongtao Shi
85 South Jiefang Road
Taiyuan, 030001, China
Taiyuan, 030001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
miRNAs in HCC, pathogenesis, and targets.
Journal: Hepatology (Baltimore, Md.)
Published: August 15, 2024
Hederagenin protects against myocardial ischemia-reperfusion injury via attenuating ALOX5-mediated ferroptosis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 15, 2023
Up-regulated lncRNA SNHG9 mediates the pathogenesis of dilated cardiomyopathy via miR-326/EPHB3 axis.
Journal: Journal of thrombosis and thrombolysis
Published: March 15, 2023
RIP3 Contributes to Cardiac Hypertrophy by Influencing MLKL-Mediated Calcium Influx.
Journal: Oxidative medicine and cellular longevity
Published: November 24, 2021
LncRNA Tincr regulates PKCɛ expression in a miR-31-5p-dependent manner in cardiomyocyte hypertrophy.
LncRNA Tincr regulates PKCɛ expression in a miR-31-5p-dependent manner in cardiomyocyte hypertrophy.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 22, 2019
Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis.
Journal: Theranostics
Published: August 23, 2019
MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
Journal: BioMed research international
Published: January 18, 2019
Role of PKA in the process of neonatal cardiomyocyte hypertrophy induced by urotensin II.
Journal: International journal of molecular medicine
Published: January 17, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026